Menu Search
Equities

Mach7 Technologies Ltd

S8M:BER

Mach7 Technologies Ltd

Actions
  • Price (EUR)0.218
  • Today's Change0.00 / 0.00%
  • Shares traded3.10k
  • 1 Year change-46.31%
  • Beta--
Data delayed at least 15 minutes, as of Nov 18 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The principal activity of the Company is the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution consists of a Vendor Neutral Archive (VNA) and data administration tools, which allow for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the cloud. Enterprise Diagnostic Viewing offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. It offers its solutions across North America, Asia Pacific, and the Middle East region.

  • Revenue in AUD (TTM)30.01m
  • Net income in AUD-7.97m
  • Incorporated1977
  • Employees90.00
  • Location
    Mach7 Technologies LtdLevel 4, 100 Albert RoadMELBOURNE 3205AustraliaAUS
  • Phone+61 39692-7222
  • Fax+61 39645-4707
  • Websitehttps://mach7t.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.